See also this year's filing and all EDGAR filings for this company.
PDF Report 0001722964_2019_Y_mAbs_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001722964, Y mAbs Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 151,532,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 205,000 |
| 3 | remainder_Assets | 187,000 |
| 4 | LiabilitiesCurrent | 9,123,000 |
| 5 | LiabilitiesNoncurrent | 224,000 |
| 6 | remainder_Liabilities | 2,050,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,961,000 |
| 9 | ResearchAndDevelopmentExpense | 34,269,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -44,000 |
| 13 | remainder_ComprehensiveNetIncome | 175,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 151,924,000 |
| 1 | Liabilities | 11,397,000 |
| 2 | Expenses | 43,230,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 140,527,000 |
| 5 | NetIncome | -43,274,000 |
| 6 | ComprehensiveNetIncome | -43,186,500 |
| 7 | BaseVar | 103,385,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.22 |
| 9 | EconomicCapitalRatio | 3.84 |